Novartis
NVS
NVS
1,011 hedge funds and large institutions have $20.7B invested in Novartis in 2018 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 373 increasing their positions, 377 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 24 → 24 (0)
1% less repeat investments, than reductions
Existing positions increased: 373 | Existing positions reduced: 377
2% less capital invested
Capital invested by funds: $21.1B → $20.7B (-$427M)
Holders
1,011
Holding in Top 10
24
Calls
$86M
Puts
$45.7M
Top Buyers
| 1 | +$71.7M | |
| 2 | +$71M | |
| 3 | +$39.2M | |
| 4 |
Two Sigma Investments
New York
|
+$36.8M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$35.6M |
Top Sellers
| 1 | -$57.3M | |
| 2 | -$40.6M | |
| 3 | -$29.1M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$26.4M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$22.6M |